MedTrace Logo

Distal Pancreatectomy Pancreatic Fistula Risk Prediction Model Validation Study

NCT05737875 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2284

Last updated 2025-07-08

No results posted yet for this study

Summary

Distal pancreas resection is a relatively rare procedure with a known risk of postoperative pancreatic fistula. Until quite recently, no valid risk prediction models for this have been available. In 2022 two different risk scores DISPAIR and D-FRS were published. The aim of this study is to compare, validate and possibly improve those scores in a international retrospective multicenter cohort.

Conditions

  • Pancreatic Fistula
  • Pancreatectomy

Sponsors & Collaborators

  • Helsinki University Central Hospital

    collaborator OTHER

  • NHS Lothian, Royal Infirmary of Edinburgh

    collaborator UNKNOWN

  • University of Edinburgh

    lead OTHER

Principal Investigators

  • Ville Sallinen, MD PhD · Helsinki University Hospital and University of Helsinki

  • Stephen J Wigmore, MD FRCSED · University of Edinburgh

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-04-07
Primary Completion
2025-04-06
Completion
2025-04-06

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05737875 on ClinicalTrials.gov